Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 324
Filter
1.
ETS2 regulates human inflammatory macrophages in IBD.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 2024 Jul 02.
Article in English | MEDLINE | ID: mdl-38956300
2.
A single-cell multiomics profile of Fontan-associated liver disease.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(7): 462, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38773285
3.
Microbiota and colorectal cancer - controlling for confounders challenges associations.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(7): 462, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38773284

Subject(s)
Colorectal Neoplasms , Gastrointestinal Microbiome , Humans , Colorectal Neoplasms/epidemiology , Gastrointestinal Microbiome/physiology
4.
Sex and ethnic disparities persist in hepatitis B management.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(7): 462, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38778180

Subject(s)
Healthcare Disparities , Hepatitis B , Humans , Healthcare Disparities/ethnology , Hepatitis B/ethnology , Female , Male , Ethnicity , Sex Factors , Hepatitis B, Chronic/ethnology , Hepatitis B, Chronic/drug therapy , Antiviral Agents/therapeutic use , United States/epidemiology
5.
Positive phase III trials for ileal bile acid transporter inhibitors.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(7): 462, 2024 Jul.
Article in English | MEDLINE | ID: mdl-38783126

Subject(s)
Clinical Trials, Phase III as Topic , Humans , Ileum , Bile Acids and Salts/metabolism , Membrane Glycoproteins/antagonists & inhibitors , Carrier Proteins
6.
A crucial Fusobacterium nucleatum clade in colorectal cancer.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(6): 375, 2024 Jun.
Article in English | MEDLINE | ID: mdl-38627536

Subject(s)
Colorectal Neoplasms , Fusobacterium nucleatum , Humans , Colorectal Neoplasms/microbiology , Fusobacterium nucleatum/genetics , Fusobacterium Infections/microbiology
7.
ECCO'24.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(5): 299, 2024 May.
Article in English | MEDLINE | ID: mdl-38480848

Subject(s)
COVID-19 , Humans , COVID-19/epidemiology , Gastroenterology/trends
8.
Sugemalimab with chemotherapy for advanced ESCC.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(4): 218, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38355754

Subject(s)
Antibodies, Monoclonal, Humanized , Carcinoma, Squamous Cell , Esophageal Neoplasms , Humans , Esophageal Neoplasms/drug therapy , Antineoplastic Combined Chemotherapy Protocols/therapeutic use
9.
A gut-liver axis in intestinal stem cell fitness.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(4): 218, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38355756

Subject(s)
Liver , Non-alcoholic Fatty Liver Disease , Humans , Intestines
10.
GLP1 agonists and risk of major adverse liver outcomes.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(4): 218, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38355757

Subject(s)
Diabetes Mellitus, Type 2 , Hypoglycemic Agents , Humans , Hypoglycemic Agents/adverse effects , Liver , Diabetes Mellitus, Type 2/drug therapy
11.
Resmetirom proves positive for NASH with liver fibrosis.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(4): 218, 2024 Apr.
Article in English | MEDLINE | ID: mdl-38360990

Subject(s)
Non-alcoholic Fatty Liver Disease , Pyridazines , Uracil/analogs & derivatives , Humans , Non-alcoholic Fatty Liver Disease/complications , Non-alcoholic Fatty Liver Disease/pathology , Liver Cirrhosis/pathology , Liver/pathology , Fibrosis
12.
A role for the gut microbiota in immune checkpoint inhibitor-induced colitis.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(3): 141, 2024 Mar.
Article in English | MEDLINE | ID: mdl-38263514

Subject(s)
Gastrointestinal Microbiome , Humans , Immune Checkpoint Inhibitors/adverse effects
13.
RET signalling controls gut motility.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(2): 71, 2024 Feb.
Article in English | MEDLINE | ID: mdl-38066101

Subject(s)
Proto-Oncogene Proteins c-ret , Signal Transduction , Humans , Proto-Oncogene Proteins c-ret/genetics , Proto-Oncogene Proteins c-ret/metabolism
14.
Risk of HCC in individuals of sub-Saharan ethnicity or descent with chronic hepatitis B in Europe.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(1): 2, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37990097

Subject(s)
Carcinoma, Hepatocellular , Hepatitis B, Chronic , Hepatitis B , Liver Neoplasms , Humans , Hepatitis B, Chronic/epidemiology , Carcinoma, Hepatocellular/epidemiology , Liver Neoplasms/epidemiology , Liver Neoplasms/etiology , Ethnicity , Europe/epidemiology , Africa South of the Sahara , Hepatitis B virus
15.
Amitriptyline as second-line treatment for IBS in primary care settings.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(1): 2, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37990098

Subject(s)
Amitriptyline , Irritable Bowel Syndrome , Humans , Amitriptyline/therapeutic use , Primary Health Care
16.
Resmetirom safe for nonalcoholic fatty liver disease.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 21(1): 2, 2024 Jan.
Article in English | MEDLINE | ID: mdl-37990099

Subject(s)
Non-alcoholic Fatty Liver Disease , Pyridazines , Humans , Uracil , Liver
17.
Understanding remodelling of bile ducts to promote polycystic liver disease.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 20(12): 759, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37789058

Subject(s)
Cysts , Liver Diseases , Humans , Liver Diseases/etiology , Bile Ducts , Liver
18.
C. difficile toxin strikes a nerve in the gut.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 20(12): 760, 2023 Dec.
Article in English | MEDLINE | ID: mdl-37816876

Subject(s)
Clostridioides difficile , Clostridium Infections , Humans , Anti-Bacterial Agents , Gastrointestinal Tract
19.
A prime role for PIEZO2 in DRG neurons in mechanosensation in the gut.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 20(11): 693, 2023 Nov.
Article in English | MEDLINE | ID: mdl-37648905

Subject(s)
Mechanotransduction, Cellular , Neurons , Humans , Neurons/metabolism , Mechanotransduction, Cellular/physiology , Ion Channels/genetics , Ion Channels/metabolism
20.
Gut-brain axis key to fat preference.
Ray, Katrina.
Nat Rev Gastroenterol Hepatol ; 19(11): 687, 2022 11.
Article in English | MEDLINE | ID: mdl-36168048

Subject(s)
Brain-Gut Axis , Gastrointestinal Microbiome , Humans , Brain
SEND TO:
Email
Export
Print
RSS
XML
SELECTION OF CITATIONS
SEARCH DETAIL